Projects funded by the NCN

Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

235 projects found matching your search criteria :

  1. LLT1 as a regulator of the immune response and a dual-target immunotherapy approach in colorectal cancer directed at NK ...

    Call: OPUS 29 , Panel: NZ6

    Principal investigator: dr Marzena Dorota Lenart

    Uniwersytet Jagielloński

  2. We are Left Without Oxygen—Now What?: Evaluation of Hypoxia-Inducible COL Family Genes in Glioblastoma Patients and Thei...

    Call: OPUS 29 , Panel: NZ4

    Principal investigator: prof. Ewa Izabela Balcerczak

    Uniwersytet Medyczny w Łodzi

  3. Next-Generation Exosome Therapy: Engineering NK Cell-Derived Vesicles for Targeted Cancer Treatment

    Call: SONATINA 9 , Panel: NZ6

    Principal investigator: dr Daria Nawrocka

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  4. An innovative approach to the elimination of cancer cells in disseminated ovarian cancer in various preclinical models b...

    Call: OPUS 28 , Panel: NZ5

    Principal investigator: dr hab. Joanna Ewa Jazowiecka-Rakus

    Kardio-Med Silesia Sp. z o.o.

  5. Targeting Telomere Integrity as an Approach to Eradicate Cancer Cells

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: dr Natalia Anna Maciejewska

    Politechnika Gdańska

  6. Parallel microevolution of metabolic plasticity and chemoresistance of cancer cells: a key to understanding cancer relap...

    Call: OPUS 28 , Panel: NZ3

    Principal investigator: prof. Jarosław Piotr Czyż

    Uniwersytet Jagielloński

  7. Harnessing NK cells and Graphene Oxide Nanoparticles for Pancreatic Ductal Adenocarcinoma Immunotherapy

    Call: OPUS 28 (LAP) , Panel: NZ7

    Principal investigator: prof. Iwona Maria Inkielewicz-Stępniak

    Gdański Uniwersytet Medyczny

  8. Supramolecular nanoparticles able to block calcium channels in cancer cells

    Call: SONATA BIS 14 , Panel: ST11

    Principal investigator: dr hab. Marek Brzeziński

    Centrum Badań Molekularnych i Makromolekularnych PAN

  9. (Lipid-FLUX) Single-cell lipidomics by spectroscopy: Quantification of the lipid transport through the development of ne...

    Call: OPUS 27 , Panel: ST4

    Principal investigator: prof. Małgorzata Anna Barańska

    Uniwersytet Jagielloński

  10. Evaluation of the relationship between doxorubicin resistance, epithelial-mesenchymal plasticity, and effects of selecte...

    Call: PRELUDIUM 23 , Panel: NZ5

    Principal investigator: Dominika Kunachowicz

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

  11. The Prognostic Utility of Circulating Tumor Cells (CTCs) Derived from the Portal Vein in Operable Colorectal Cancer Pati...

    Call: PRELUDIUM 23 , Panel: NZ5

    Principal investigator: Claudia Dompé

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  12. CAR(dio)-T(oxicity)- Engineered Heart Tissue model for CAR-T cardiotoxicity evaluation

    Call: SONATA 19 , Panel: NZ7

    Principal investigator: dr Agnieszka Joanna Zimna

    Instytut Genetyki Człowieka PAN

  13. Cellular senescence as a new mechanism in development and progression of head and neck cancer

    Call: OPUS 26 , Panel: NZ5

    Principal investigator: prof. Michał Mateusz Masternak

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  14. Defining the transcriptional and epigenetic state of tumor cells with increased plasticity and the epithelial-endothelia...

    Call: OPUS 26 , Panel: NZ5

    Principal investigator: dr hab. Agnieszka Kobielak

    Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego

  15. Organometallic (Fe, Ru, Ir, Os) phospho-inducers of drug-resistant cancer cells' ferroptosis

    Call: OPUS 26 , Panel: ST4

    Principal investigator: dr hab. Urszula Katarzyna Komarnicka

    Uniwersytet Wrocławski, Wydział Chemii

  16. Design and microfluidic synthesis of hybrid nanocarriers stabilized by novel sugar surfactants as a potential anticancer...

    Call: SONATA BIS 13 , Panel: ST4

    Principal investigator: dr hab. Urszula Jolanta Bazylińska

    Politechnika Wrocławska

  17. Persistent luminescence thermometry of nano-phosphors and their biomedical potential

    Call: OPUS 25 , Panel: ST5

    Principal investigator: dr Justyna Anna Zeler

    Uniwersytet Wrocławski, Wydział Chemii

  18. Quantitation of metabolic turnover in single cancer cells by infrared microscopy

    Call: OPUS 25 , Panel: NZ1

    Principal investigator: dr Luca Quaroni

    Uniwersytet Jagielloński, Wydział Chemii

  19. Targeting Energy Metabolism for Precision Cancer Therapy: Novel Inhibitors of LDH-A and PDK1 as Potential Strategies to ...

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Marika Anna Frańczak

    Gdański Uniwersytet Medyczny, Wydział Lekarski

  20. Investigating the anti-cancerous effect of antioxidant extract from spent coffee grounds on the functioning of normal an...

    Call: PRELUDIUM 22 , Panel: NZ5

    Principal investigator: Adrianna Maria Piasek

    Politechnika Warszawska, Wydział Chemiczny

  21. The study of the effect of hypoxia on the metabolism of exogenous ferritin and its role in the regulation of free iron i...

    Call: PRELUDIUM 22 , Panel: NZ5

    Principal investigator: dr Małgorzata Maria Kubiak-Krupa

    Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, Centrum Immunoterapii Komórkowych

  22. Functional consequences of loss of chromosome Y (LOY) in immune cells in the context of cancer - ex vivo and in vitro st...

    Call: OPUS 25 , Panel: NZ2

    Principal investigator: dr Jan Dumański

    Gdański Uniwersytet Medyczny, Międzynarodowa Agenda Badawcza

  23. Myeloid cell subpopulations as a source of effector cells for anticancer therapies using CAR chimeric receptors

    Call: OPUS 25 , Panel: NZ6

    Principal investigator: dr hab. Angelika Muchowicz

    Warszawski Uniwersytet Medyczny, Wydział Lekarski

  24. Elucidation of the role of ERM and merlin proteins in the process of formation of entotic structures and identification ...

    Call: PRELUDIUM 22 , Panel: NZ3

    Principal investigator: Agata Maria Gaweł

    Warszawski Uniwersytet Medyczny

  25. 3D-printed bone implants - Exploring the relationship between the chemical and spatial structure of implants and their s...

    Call: OPUS 25 , Panel: ST4

    Principal investigator: prof. Edyta Proniewicz

    Akademia Górniczo-Hutnicza im. Stanisława Staszica w Krakowie, Wydział Odlewnictwa

  26. Spatial Determinants of Immunotherapy Resistance in Cancer

    Call: WEAVE-UNISONO , Panel: NZ6

    Principal investigator: dr Marcin Tabaka

    Instytut Chemii Fizycznej Polskiej Akademii Nauk, Międzynarodowe Centrum Badań Oka

  27. Determination of the SNAIL1 transcription factor effect on biology cancer stem cells in rhabdomyosarcoma model

    Call: OPUS 24 , Panel: NZ5

    Principal investigator: prof. Marcin Marek Majka

    Uniwersytet Jagielloński, Collegium Medicum

  28. Precise molecular characterization of circulating tumour cells in patients with triple negative breast cancer using high...

    Call: OPUS 24 , Panel: NZ7

    Principal investigator: prof. Stefano Volinia

    Uniwersytet Warszawski, Centrum Nauk Biologiczno-Chemicznych

  29. Development and differentiation of early-stage" myeloid-derived suppressor cells (e-MDSCs) in colorectal cancer – the ro...

    Call: OPUS 24 , Panel: NZ6

    Principal investigator: dr hab. Jarosław Tomasz Baran

    Uniwersytet Jagielloński, Collegium Medicum

  30. Senolytic nanoplatform to target and eliminate skin cancer Zombie cells

    Call: M-ERA.NET 2022 , Panel: ST5

    Principal investigator: dr hab. Anna Karolina Lewińska

    Uniwersytet Rzeszowski, Kolegium Nauk Przyrodniczych

  31. Role of microparticles derived from platelets and cancer cells in colorectal cancer progression – how to stop them or tu...

    Call: OPUS 24 , Panel: NZ5

    Principal investigator: prof. Maria Anna Kowalska

    Instytut Biologii Medycznej PAN

  32. Extracellular matrix and matrix-processing cells in pathophysiology of pancreatic cancer

    Call: SONATA BIS 12 , Panel: NZ4

    Principal investigator: dr Monika Anna Jakubowska

    Uniwersytet Jagielloński, Małopolskie Centrum Biotechnologii Uniwersytetu Jagiellońskiego

  33. Pancreatic diseases from a new perspective - ion signalling, mitochondria and the TRPA1 channel

    Call: SONATA BIS 12 , Panel: NZ3

    Principal investigator: dr Paweł Eugeniusz Ferdek

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

  34. A smart stride for cancer: synergistic effect of co-delivery chemo- andphototherapeutic agents using magneto-fluorescent...

    Call: POLONEZ BIS 2 , Panel: NZ7

    Principal investigator: dr Prachi Uttam Ghoderao

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  35. Histone demethylase inhibitors as chemosensitivity modulators in the treatment of head and neck squamous cell carcinoma

    Call: PRELUDIUM 21 , Panel: NZ7

    Principal investigator: Dawid Dariusz Dorna

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  36. Highly-internalizing intrinsically fluorescent oligomeric cytotoxic conjugate targeting breast cancer cells overproducin...

    Call: PRELUDIUM 21 , Panel: NZ1

    Principal investigator: dr Natalia Porębska

    Uniwersytet Wrocławski, Wydział Biotechnologii

  37. The role of 5-methylcytosine RNA methyltransferases in the regulation of cancer cell responses to extracellular and exog...

    Call: OPUS 22 , Panel: NZ2

    Principal investigator: dr hab. Anna Karolina Lewińska

    Uniwersytet Rzeszowski, Collegium Medicum Wydział Biotechnologii

  38. Electrospun nanofiber-based nanoplatform for delivery of new nutraceutical derivatives to eliminate chemotherapy-induced...

    Call: OPUS 22 , Panel: NZ7

    Principal investigator: dr hab. Maciej Antoni Wnuk

    Uniwersytet Rzeszowski, Collegium Medicum

  39. Combinatorial targeting of non-genetic sources of cell-to-cell heterogeneity to overcome fractional killing of cancer ce...

    Call: SONATA 17 , Panel: NZ3

    Principal investigator: dr Jarosław Walczak

    Instytut Podstawowych Problemów Techniki Polska Akademia Nauk

  40. New strategy for overcoming resistance to chemotherapy of ovarian cancer by modulation of the canonical and non-canonica...

    Call: OPUS 22 , Panel: NZ5

    Principal investigator: prof. Radosław Januchowski

    Uniwersytet Zielonogórski, Collegium Medicum

  41. Adaptation of mitochondrial functions to stress caused by plastic dust/pollution; action of mitochondrial retrograde sig...

    Call: OPUS 22 , Panel: NZ5

    Principal investigator: prof. Joanna Bogumiła Szczepanowska

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

  42. In vitro tracing of cellular senescence to cancer stem cell formation using a nanoparticle-based reporter system

    Call: OPUS 22 , Panel: NZ3

    Principal investigator: dr Patrick McDevitt Perrigue

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Centrum NanoBioMedyczne

  43. Identification of the adipogenic niche derived molecules as the factors driving the colorectal cancer cell progression

    Call: OPUS 22 , Panel: NZ3

    Principal investigator: dr hab. Dorota Nowak

    Uniwersytet Wrocławski, Wydział Biotechnologii

  44. RE-SENSE: Dual-loaded lipid nanoparticles to overcome the resistance of non-small cell lung cancer cells to personalized...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Mikołaj Czajkowski

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  45. Biotinylated boronic acid derivative as a tool for targetable detection of oxidants in cancer cells

    Call: PRELUDIUM 20 , Panel: ST4

    Principal investigator: Przemysław Adam Siarkiewicz

    Politechnika Łódzka, Wydział Chemiczny

  46. Mechanisms of generation of myeloid-derived suppressor cells of monocyte origin (Mo-MDSCs) by extracellular vesicles fro...

    Call: PRELUDIUM 20 , Panel: NZ6

    Principal investigator: dr Izabela Siemińska

    Uniwersytet Jagielloński, Collegium Medicum

  47. The role of circular RNA – MALAT1 in breast-to-brain cancer metastasis.

    Call: PRELUDIUM 20 , Panel: NZ3

    Principal investigator: Adrian Łukasz Szczepaniak

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  48. MicroRNAome maturation control and its application in selective targeting of cancer stem cells

    Call: OPUS 20 , Panel: NZ5

    Principal investigator: dr Jakub Godlewski

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  49. Smart polymer delivery systems for photosensitizers to cancer cells

    Call: PRELUDIUM BIS 2 , Panel: NZ7

    Principal investigator: prof. Tomasz Adam Gośliński

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  50. The role of vitamin D receptor in 5-fluorouracil responsiveness of colorectal cancer cells

    Call: SONATA 16 , Panel: NZ5

    Principal investigator: dr Magdalena - Milczarek

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

O Narodowym Centrum Nauki

Finansowanie nauki

Współpraca zagraniczna

Centrum prasowe

Deklaracja dostępności
Przetwarzanie danych osobowych
Polityka cookies

Partnerzy